0
Skip to Content
TruScreen
The TruScreen Device
HPV Test Kits
Clinical Performance
Development History
Eliminating Cervical Cancer
Markets
Our People
Investors
Contact
News
TruScreen
The TruScreen Device
HPV Test Kits
Clinical Performance
Development History
Eliminating Cervical Cancer
Markets
Our People
Investors
Contact
News
The TruScreen Device
HPV Test Kits
Clinical Performance
Development History
Eliminating Cervical Cancer
Markets
Our People
Investors
Contact
News

Screening Program in Vietnam

25 Nov
Previous
Previous

TruScreen Half Year Results
Next
Next

Germany's Springer Nature Journal Publication on TruScreen

A world without cervical cancer.

Quick links

Contact Us

The TruScreen Device

Markets & Distributors

Privacy Policy

Contact

info@truscreen.com

TruScreen Group Limited (NZX/ASX: TRU) is a New Zealand and Australian listed medical device company that has developed an AI-enabled device that can detect precancerous and cancerous cervical changes in real-time via optical and electrical measurements of cervical tissue. Unlike many cervical screening devices, that have only triage/adjunct functionality, the TruScreen device is registered as a stand alone primary screening tool.

© 2025 Truscreen Group Ltd. All rights reserved.